ERBB2 and prostate cancer: FOXP3 was found to inhibit tumor cell growth, serving as an important repressor for breast cancer oncogene SKP2 and HER2 [10, 11], and FOXP3–miR-146–NF-kB Axis has been suggested in leading to apoptosis during tumor initiation and tumor suppression in prostate cancer [36].